# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™...
Appoints proven atrial fibrillation medical technology leader Burke T. Barrett as President and Chief Executive OfficerFormer P...
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(...
Robert Duggan, the Company's Executive Chairman and majority stockholder, has indicated his support for the rights offering...